Reprieve Cardiovascular
PrivateLast Round
Series B
Aug 13, 2025
Total Funding Raised
$171M
Company Overview
Reprieve Cardiovascular is a medical device company that develops intelligent fluid management technologies for the treatment of acute decompensated heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reprieve Cardiovascular Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Reprieve Cardiovascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 13, 2025 | ||||
| Series B | Aug 13, 2024 | ||||
| Series A | Feb 20, 2024 | ||||
| Seed | Sep 18, 2018 |
Key People
Founding team and executive leadership
Reprieve Cardiovascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A, Series B |
| Arboretum Ventures | Series A, Series B |
| Lightstone Ventures | Series B, Series A |
| Cadence Healthcare Ventures | Series B |
| Santé Ventures | Series B, Series A |
| Genesis Capital | Series B, Series A |
| Cadence Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 13, 2024
$61M round completed.
Reprieve Cardiovascular Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Reprieve Cardiovascular's valuation, stock price, and market status.